Medipal Holdings Corp
TSE:7459
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2 182.5
2 923
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| JP |
|
Medipal Holdings Corp
TSE:7459
|
585.1B JPY |
Loading...
|
|
| US |
|
Mckesson Corp
NYSE:MCK
|
102.5B USD |
Loading...
|
|
| US |
|
Cencora Inc
NYSE:COR
|
68.5B USD |
Loading...
|
|
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
68.6B USD |
Loading...
|
|
| US |
|
Cardinal Health Inc
NYSE:CAH
|
50.8B USD |
Loading...
|
|
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
35.5B AUD |
Loading...
|
|
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
66.2B CNY |
Loading...
|
|
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
64.8B CNY |
Loading...
|
|
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9.1B USD |
Loading...
|
|
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW |
Loading...
|
|
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
64.7B HKD |
Loading...
|
Market Distribution
| Min | -125 500% |
| 30th Percentile | 4.2% |
| Median | 7% |
| 70th Percentile | 10.6% |
| Max | 9 743.7% |
Other Profitability Ratios
Medipal Holdings Corp
Glance View
Medipal Holdings Corp., a longstanding pillar in Japan’s healthcare and pharmaceutical distribution network, tells a story of efficiency and dedication to health. Born from a strategic merger in the late 20th century, Medipal has established itself as a key player in the intricate world of pharmaceutical and medical supply logistics. The company's operations are woven into the fabric of Japan’s healthcare infrastructure, where precision and reliability form the foundation of its success. By orchestrating the smooth flow of pharmaceuticals, medical devices, and health-related products from manufacturers to a myriad of healthcare facilities and retail outlets, Medipal plays a vital role in ensuring that medical professionals and patients alike have timely access to necessary products. At the heart of Medipal's business model is a comprehensive supply chain that seamlessly connects an extensive network of partners. With sophisticated distribution centers operating as logistical powerhouses, Medipal leverages cutting-edge technology to optimize inventory management and delivery systems. This enables the company not only to drive efficiencies but also to create value by reducing costs and enhancing the speed and reliability of distributions. Revenue streams are generated primarily through distribution fees and the strategic management of logistics services. As Medipal continues to expand its reach and refine its operations, it remains steadfast in its commitment to being an indispensable ally in Japan's healthcare landscape, where reliability and trust are of paramount importance.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Medipal Holdings Corp is 1.4%, which is in line with its 3-year median of 1.4%.
Over the last 3 years, Medipal Holdings Corp’s Operating Margin has increased from 1.4% to 1.4%. During this period, it reached a low of 1.3% on Sep 30, 2023 and a high of 1.5% on Jun 30, 2025.